Teva a constant growth company, has a current market (and equilibrium) stock price of $20.00. Teva's next dividend, D1, is forecasted to be $2.00. and Teva is growing at an annual rate of 6 percent. Teva has a beta coefficient of 1.2, and the required rate of return on the market is 15 percent. As Teva's financial manager, you have access to insider information concerning a switch in product lines that would not change the growth rate, but would cut Teva's beta coefficient in half. If you buy the stock at the current market price, what is your expected percentage capital gain? 43% 23% 33% 53% There would be a capital loss